Reduced early mortality with Daratumumab-based frontline therapy in AL amyloidosis: A retrospective cohort study

Am J Hematol. 2024 Mar;99(3):477-479. doi: 10.1002/ajh.27179. Epub 2023 Dec 15.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antibodies, Monoclonal / therapeutic use
  • Humans
  • Immunoglobulin Light-chain Amyloidosis* / drug therapy
  • Retrospective Studies
  • Treatment Outcome

Substances

  • daratumumab
  • Antibodies, Monoclonal